New Zealand’s Medical Research Institute has found that Celebrex users are nearly twice as likely to suffer a heart attack as those taking other arthritis drugs, commonly known as Cox-2 inhibitors. Last August, Pfizer, the manufacturer of Celebrex, put a “black box” warning on the drug yet Celebrex stayed on the market. The black box warning is the most severe of the labels placed on pharmaceutical drugs. Celebrex remains the only Cox-2 inhibitor still on the market today.
Admitted to practice law in all federal multidistrict litigation courts, the California State Bar and the Florida Bar. His philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.
Comments for this article are closed.